NOVATEK announces consolidated IFRS results for Q2 and H1 of 2021
PAO NOVATEK today released its consolidated interim condensed financial statements as of and for the three and six months ended 30 June 2021 prepared in accordance with International Financial Reporting Standards (“IFRS”).
IFRS Financial Highlights (in millions of Russian roubles except as stated)
|
2Q 2021 |
2Q 2020 |
1H 2021 |
1H 2020 |
|
|
260,552 |
140,641 |
Oil and gas sales |
501,301 |
323,236 |
|
3,900 |
3,298 |
Other revenues |
7,734 |
5,265 |
|
264,452 |
143,939 |
Total revenues |
509,035 |
328,501 |
|
(195,164) |
(116,239) |
Operating expenses |
(373,983) |
(262,774) |
|
186 |
(14,077) |
Other operating income (loss) |
(436) |
(47,313) |
|
69,474 |
27,336 |
Normalized profit from operations* |
134,616 |
66,237 |
|
83,247 |
37,655 |
Normalized EBITDA of subsidiaries* |
159,872 |
83,038 |
|
163,230 |
71,270 |
Normalized EBITDA including share in |
307,066 |
171,938 |
|
(14,648) |
(50,903) |
Finance income (expense) |
(13,040) |
90,550 |
|
58,364 |
72,007 |
Share of profit (loss) of joint ventures, |
73,211 |
(73,224) |
|
113,190 |
34,727 |
Profit before income tax |
194,787 |
35,740 |
|
99,287 |
41,564 |
Profit attributable to |
164,439 |
10,884 |
|
88,958 |
21,220 |
Normalized profit attributable to |
164,731 |
74,767 |
|
29.63 |
7.07 |
Normalized basic and diluted earnings per share*, |
54.86 |
24.87 |
|
47,381 |
61,340 |
Cash used for capital expenditures |
88,827 |
102,483 |
* Excluding the effects from disposal of interests in subsidiaries and joint ventures (recognition of a net gain on disposal and subsequent non-cash revaluation of contingent consideration).
